MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1

Yaming Li(Qilu Hospital of Shandong University), Qifeng Yang(Qilu Hospital of Shandong University), Hanwen Zhang(Dongguan People’s Hospital), Ying Liu(Qilu Hospital of Shandong University), Yuting Sang(Qilu Hospital of Shandong University), Liyu Jiang(Qilu Hospital of Shandong University), Xiaojin Song(Qilu Hospital of Shandong University), Yiran Liang(Qilu Hospital of Shandong University)
Cell Death and Disease
January 11, 2018
10.1038/s41419-017-0030-7
Cited by 190

Related Papers

Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
|Seminars in Cancer Biology|2019|1k
circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer
|Molecular Therapy|2019|513
RETRACTED ARTICLE: LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis
|Molecular Cancer|2020|396
LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215
|Journal of Cellular Physiology|2018|301
Ultrasensitive single-cell proteomics workflow identifies >1000 protein groups per mammalian cell
|Chemical Science|2020|245